Devin Carty
Board Member
Devin Carty has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and healthcare system operator.
Devin is the CEO for Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and provides oversight for 25 portfolio companies. Devin’s historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP).
Devin has cofounded several companies including Wellvana Health, Trilliant Health, and Clariture Health.
- For Wellvana, he serves as chairman of the board, recently transitioning from the role of CEO.
- For Trilliant Health, he served as chairman from its inception until the recapitalization with Primus Capital. Devin continues to serve as a board member for Trilliant, as well as for Ovia, Mployer Advisory, OncoLens and Hashed Health.
- For Clariture Health, as CEO, Devin led the company to increase monthly recurring revenue by 10x and delivered a contribution margin return on marketing investment to clients of 14x. Clariture merged with Aegis to form Trilliant.
At Cancer Treatment Centers of America, Devin served as executive vice president, chief talent officer, and chief strategy officer. He led the enterprise growth strategy, and my team advanced the culture, increasing employee engagement to the 93rd percentile, and enhanced patient experience, earning an NPS score of 96 and receiving a five-star rating from CMS.
At Vanguard Health Systems, Devin was part of the senior leadership team that grew the organization to 29 hospitals, more than 46,000 employees, and over $6.5 billion in revenue. During his tenure, they completed an initial public offering in 2011 and the company’s sale to Tenet for $4.3 billion in 2013. Devin’s roles included corporate chief talent officer, chief experience officer, and chief marketing officer.
At Gallup Consulting, Devin served as a partner for the healthcare division, consulting for some of the world’s leading healthcare organizations–Cleveland Clinic, HCA, Trinity, Vanguard, and Henry Ford Health System.
Devin Carty has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of the Congo, and pursued healthcare solutions as an entrepreneur, venture capitalist, and healthcare system operator.
Devin is the CEO for Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and provides oversight for 25 portfolio companies. Devin’s historical investments include AmericanWell (IPO), OneDrop (recapitalized by Bayer), Valify (acquired by HCA Healthcare), Trilliant Health (recapitalized by Primus Capital), Jvion (acquired by JMI Equity), Avizia (acquired by AmericanWell), Healthcare Bluebook (acquired by Primus Capital), and Clockwise.MD (acquired by DocuTAP).
Devin has cofounded several companies including Wellvana Health, Trilliant Health, and Clariture Health.
- For Wellvana, he serves as chairman of the board, recently transitioning from the role of CEO.
- For Trilliant Health, he served as chairman from its inception until the recapitalization with Primus Capital. Devin continues to serve as a board member for Trilliant, as well as for Ovia, Mployer Advisory, OncoLens and Hashed Health.
- For Clariture Health, as CEO, Devin led the company to increase monthly recurring revenue by 10x and delivered a contribution margin return on marketing investment to clients of 14x. Clariture merged with Aegis to form Trilliant.
At Cancer Treatment Centers of America, Devin served as executive vice president, chief talent officer, and chief strategy officer. He led the enterprise growth strategy, and my team advanced the culture, increasing employee engagement to the 93rd percentile, and enhanced patient experience, earning an NPS score of 96 and receiving a five-star rating from CMS.
At Vanguard Health Systems, Devin was part of the senior leadership team that grew the organization to 29 hospitals, more than 46,000 employees, and over $6.5 billion in revenue. During his tenure, they completed an initial public offering in 2011 and the company’s sale to Tenet for $4.3 billion in 2013. Devin’s roles included corporate chief talent officer, chief experience officer, and chief marketing officer.
At Gallup Consulting, Devin served as a partner for the healthcare division, consulting for some of the world’s leading healthcare organizations–Cleveland Clinic, HCA, Trinity, Vanguard, and Henry Ford Health System.